DoctorDirectory.ai
Menu

Dr. Kershaw Patel, MD

Not yet claimed

Cardiologist · Physician (MD)

Houston, TX

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Kershaw Patel? Claim this profile.

Kershaw Patel is a heart doctor in Houston, Texas. He practices with Houston Methodist DeBakey Cardiology Associates.

About Dr. Kershaw Patel, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Kershaw V. Patel is a cardiologist at the Houston Methodist DeBakey Heart & Vascular Center in Houston, Texas. He earned his medical degree from the University of Texas Medical Branch at Galveston, completed internal medicine residency at the University of Chicago, and finished a cardiovascular disease fellowship plus an NIH T32 research fellowship at UT Southwestern in Dallas.

His practice focuses on preventive and cardiometabolic cardiology. Patients commonly see him for cardiology consultations, cardiovascular screening, chest pain, ECG/EKG testing, and high blood pressure. He sees patients through Houston Methodist DeBakey Cardiology Associates and has been listed with the Division of Cardiovascular Prevention and Wellness.

His research looks at new ways to screen for and prevent heart disease, especially preventing heart failure in people with diabetes, obesity, and related risk factors. He was first author of a Circulation study on heart failure screening in adults with diabetes, and he is listed as Chair-Elect on committees of two American Heart Association councils: Epidemiology and Prevention, and Lifestyle and Cardiometabolic Health.

Federal Open Payments records for 2021–2025 show $14,701.07 in industry payments to him across 26 records, mostly from Novo Nordisk ($9,438.17) and Roche Diagnostics ($4,999). Payments from drug and device companies are common and legal, and are reported publicly by Medicare.

Training and fellowship
Medical degree from UT Medical Branch at Galveston, internal medicine residency at the University of Chicago, and cardiovascular disease plus NIH T32 research fellowship at UT Southwestern. zocdoc.com
Board certification
Listed as certified by the American Board of Internal Medicine in Internal Medicine and Cardiovascular Disease. zocdoc.com
AHA committee role
Listed as Chair-Elect on a committee of the American Heart Association Council on Epidemiology and Prevention. professional.heart.org
Second AHA committee role
Also listed as Chair-Elect on a committee of the AHA Council on Lifestyle and Cardiometabolic Health. professional.heart.org
Published heart failure research
First author of a pooled cohort study in Circulation on screening to predict and prevent heart failure in adults with diabetes who do not have atherosclerotic cardiovascular disease. ahajournals.org
Prevention research focus
His research centers on preventing cardiovascular disease with new screening strategies, with a focus on heart failure prevention in people with diabetes, obesity, and other cardiometabolic risks. zocdoc.com
Common reasons for visits
Patients commonly book him for cardiology consultation, cardiovascular screening, chest pain, ECG/EKG testing, and hypertension. zocdoc.com
Patient ratings
Zocdoc shows a 4.96 average rating across 33 patient reviews, with new patients and telehealth accepted. zocdoc.com
Hospital affiliation
Affiliated with Houston Methodist Hospital and practices with Houston Methodist DeBakey Cardiology Associates. healthgrades.com
Industry payments reported
CMS Open Payments lists $14,701.07 across 26 records for 2021–2025, led by Novo Nordisk ($9,438.17) and Roche Diagnostics ($4,999). openpaymentsdata.cms.gov

Worth knowing

  • Healthgrades displays a label saying he "has extensive experience in Adult Congenital Heart Conditions." This is generated by that site from insurance claims data, not a statement from the doctor or his employer. healthgrades.com
  • His board certification was found on a commercial directory listing and was not checked against the American Board of Internal Medicine's own verification tool during this research. zocdoc.com
  • A LinkedIn profile using his name and employer exists, but it shows only three connections and it could not be confirmed that he controls it. linkedin.com

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$14,701

26 payments

2021$122
2022$4,525
2023$4,819
2024$72
2025$5,163

Top payers

  • Novo Nordisk Inc$9,438
  • Roche Diagnostics Corporation$4,999
  • Amgen Inc.$135
  • Corcept Therapeutics$50
  • PFIZER INC.$38

Payment types

  • Consulting Fee$14,149
  • Food and Beverage$455
  • Education$97

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: houstonmethodist.org · scholars.houstonmethodist.org · x.com · linkedin.com · doximity.com · blogs.the-hospitalist.org · zocdoc.com · healthgrades.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·